Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy
- PMID: 8457978
- PMCID: PMC358264
- DOI: 10.1128/CMR.6.1.22
Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy
Abstract
Antimicrobial susceptibility testing (AST) of Neisseria gonorrhoeae has been under development since the early days of antimicrobial agents. However, it is rarely applied to clinical isolates today. The history of the various in vitro tests to determine the susceptibility of N. gonorrhoeae to antibiotics is rich with evidence that these results predict response to therapy for almost all agents tested. Further, AST is a useful and important aspect of strain characterization and disease epidemiology in conjunction with the more specific but laborious techniques of auxotyping, serotyping, and plasmid analysis. Current technology has overcome many of the objections to AST for N. gonorrhoeae with standardization of test media and the development of an accurate disk diffusion AST method that is suited to most clinical laboratories regardless of volume or level of technical expertise. Ironically, the very low level of resistance to the current primary treatment strategy in the United States, ceftriaxone or another potent cephalosporin, makes the use of AST somewhat superfluous.
Similar articles
-
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1. MMWR Surveill Summ. 2016. PMID: 27414503
-
[Use of molecular biology in the epidemiological characterization of Neisseria gonorrhoeae].Salud Publica Mex. 1992 May-Jun;34(3):292-300. Salud Publica Mex. 1992. PMID: 1615347 Spanish.
-
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.BMC Infect Dis. 2018 Jan 17;18(1):44. doi: 10.1186/s12879-018-2944-9. BMC Infect Dis. 2018. PMID: 29343220 Free PMC article.
-
Expanding U.S. Laboratory Capacity for Neisseria gonorrhoeae Antimicrobial Susceptibility Testing and Whole-Genome Sequencing through the CDC's Antibiotic Resistance Laboratory Network.J Clin Microbiol. 2020 Mar 25;58(4):e01461-19. doi: 10.1128/JCM.01461-19. Print 2020 Mar 25. J Clin Microbiol. 2020. PMID: 32024723 Free PMC article. Review.
-
Laboratory methods for the detection and phenotypic characterization of Neisseria gonorrhoeae strains resistant to antimicrobial agents.Sex Transm Dis. 1988 Oct-Dec;15(4):225-33. doi: 10.1097/00007435-198810000-00009. Sex Transm Dis. 1988. PMID: 3147527 Review.
Cited by
-
Prevalence of Selected Sexually Transmitted Infection (STI) and Associated Factors among Symptomatic Patients Attending Gondar Town Hospitals and Health Centers.Ethiop J Health Sci. 2017 Nov;27(6):589-600. doi: 10.4314/ejhs.v27i6.4. Ethiop J Health Sci. 2017. PMID: 29487468 Free PMC article.
-
Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods.J Clin Microbiol. 1996 Feb;34(2):479-81. doi: 10.1128/jcm.34.2.479-481.1996. J Clin Microbiol. 1996. PMID: 8789046 Free PMC article.
-
Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories.J Clin Microbiol. 2000 Sep;38(9):3341-8. doi: 10.1128/JCM.38.9.3341-3348.2000. J Clin Microbiol. 2000. PMID: 10970381 Free PMC article.
-
A Review of Recent Advances in Our Understanding of Neisseria gonorrhoeae.Cureus. 2023 Aug 14;15(8):e43464. doi: 10.7759/cureus.43464. eCollection 2023 Aug. Cureus. 2023. PMID: 37711920 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases